Skip to main content
WRBYWarby Parker Inc.Sell5.0·$24.71+1.69%

Warby Parker (WRBY) Q2 2026 earnings — TrendMatrix coverage

BEAT+30.0% vs estimateEPS $0.15 vs $0.11 estVerdict SellHold

Reported

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure

Event detail · Q2 2026

Key numbers

Reported EPS
$0.15
Estimate
$0.11
Surprise
+30.0%
Revenue (period 2026-06-30)
$235.5M
Score at report (before → after)
4.54.5/10

Revenue source: xbrl.

Report record · Q2 2026

How the report landed

Warby Parker (WRBY) beat the $0.11 estimate with diluted EPS of $0.15 — a large 30.0% upside surprise. TrendMatrix's engine moved from Sell (4.5/10) to Hold at 4.5/10 after the report.

Current read · as of 2026-09-14

Where TrendMatrix's rating stands now

TrendMatrix currently rates WRBY Sell at 5.0/10.

2 of the last 4 quarters beat the estimate; this quarter's +30.0% surprise compares with a +3.4% four-quarter average. Next scheduled report: 2026-11-05.

What supports the rating

  • Sector modifier (Healthcare): +0.5

What argues against it

  • Thin upside margin: 7.3%
  • V7 low-quality RISK_OFF penalty: -0.5 (Q=4.4)
  • Negative momentum

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current engine read

The levels TrendMatrix's engine tracks

Current price
$24.71
Price target
$26.50
Stop
$22.98
Upside to target
+7.2%
Reward-to-risk
0.8:1

The stock trades at 411.8× trailing but 40.2× forward earnings — consensus estimates already build in a substantial earnings recovery.

Risk check: RSI 29 — a level conventionally read as oversold.

Model outputs from TrendMatrix’s engine as of 2026-09-14 — shown for context, not personalized investment advice.

Healthcare context

WRBY at TrendMatrix's latest read

Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.

Industry
Medical Instruments & Supplies
Market cap
$3.05B
P/E (fwd)
40.2
P/E (ttm)
411.8
52-week range
$14.96$31.00
Off 52-week high
20.3%
RSI (14)
29
Volume vs avg
0.90×
Score today
5.0/10

Earnings figures are sourced from TrendMatrix’s pipeline (EPS: existing earnings extraction; revenue: SEC XBRL company facts where available, yfinance-provisional otherwise). Not a buy/sell rating, a price target, or investment advice — see the current verdict on the stock’s main page for TrendMatrix’s live read.

Home Stocks WRBY Earnings Q2 2026 earnings